Europe OTC Distribution in 2016: The New Global Agenda – Research and Markets

OTC Distribution in Europe – the 2016 edition is a long running in-depth study that explores and tracks change. It identifies the driving factors coming into play which will influence the distribution channel environment for the consumer healthcare industry now and in the future. It provides a wealth of knowledge and comprehensive statistics and analysis covering 20 European countries, together with insights into an increasingly complex market sector from a highly respected strategy consultant, James W Dudley.

A new and rapidly evolving competitive agenda is enveloping the supply networks which serve 473 million people living in 20 European countries with 29 billion worth of consumer health products.

Merger and acquisition activities are globalizing the supply chain and intensifying competitive pressures. Cross border mixed pharmacy chains are reshaping the consumer channel. Powerful retail brands employ digital technologies to drive multi-channel strategies and Internet pharmacies are undermining consumer prices.

Independent pharmacies are forming collectives, affiliated groupings and virtual chains in an attempt to remain competitive. Reducing government payments toward reimbursed prescription drugs and pressures on fees are forcing pharmacies to seek business from non price regulated consumer care ranges. Furthermore, deregulation of the non-prescription healthcare sector is shifting consumer demand to non-pharmacy channels in a number of countries.

– 85% of the consumer health market turnover passes through 145,143 pharmacies, while 15% is accessed through supermarkets, discounters, convenience stores, druggists and Internet and mail order pharmacies

– 15% of European pharmacies are branches of wholly owned pharmacy multiples many of them international chains

– One in three European pharmacies is a member of a virtual chain’ or affiliated cooperation group of independent pharmacies

– Internet pharmacies are playing an increasing role in consumers sources and choices of purchases for consumer healthcare and related products and services especially in Germany, the UK and Belgium

– Nearly half of the intermediary pharmaceutical wholesale market is controlled by a handful of players

Chapter 1 Distribution of OTC Medicines in Europe – Introduction, Market Definitions and Summary of Key Issues

Chapter 2 Pharmaceutical Distributors New Strategies in Europe

Chapter 3 Profiles of Companies Driving the European Pharmaceutical Supply Chain

Chapter 4 New Channels for Consumer Healthcare in Europe

Chapter 5 OTC Distribution in Belgium

Chapter 6 OTC Distribution in France

Chapter 7 OTC Distribution in Germany

Chapter 8 OTC Distribution in Italy

Chapter 9 OTC Distribution in the Netherlands

Chapter 10 OTC Distribution in Spain

Chapter 11 OTC Distribution in the United Kingdom

Chapter 12 OTC Distribution in Austria & Switzerland

Chapter 13 OTC Distribution in the Nordic Region

Chapter 14 OTC Distribution in Central Europe

Chapter 15 Conclusions of the Report

– A.S. Watson

– AAH Pharmaceuticals (Celesio)

– AAH Wilkinson Healthcare

– Alliance Healthcare (WBA) Previously SA Farmacutica Aragonesia (SAFA)

– Alma Patika

– Almus

– AmedisUE

– AmerisourceBergen

– Apokjeden Tamro

– Apoteket AB

– Apoteket AB

– Apoteksgruppen

– Apotheke zur Rose

– Astera CERP Rouen

– Auchan

– BENU Pharmacy

– Belmedis Welcoop

– Benu (Phoenix )

– Benu Apotheek (Escura Apotheek)

– Benue Phoenix

– Bestway Group

– Boots

– Brocacef Holdings Benu Pharmacy

– CEFARM Pharmaceutical SA

– CERP Lorraine

– CERP SA Astera cooperative group


– Carrefour

– Catena

– Cecofar

– Cefarm 24

– Celesio Italy

– Cohens Chemist

– Cosmetic Products